In the Washington Post, Michelle Andrews has a fascinating piece called “Like a Lollipop at the Dentist’s, but for Grown-Ups” on value-based pricing and insurance design pros and cons wherein she discussed how companies are … Continue reading at ComplianceZen.com →
From the Blog
Lowering Liability Risks with Supplier Qualification
FDA Compliance Training – Free Consulting?
From the NIH – Biotechnology Landscape 2020
FDA Forecast for 2012
From the PCP Council Science Symposium
Client Success Stories
“We'd received multiple 483s from an FDA inspection and lacked the resources to quickly solve the issues. Cerulean conducted a gap analysis, created a practical roadmap for resolution, and then helped lead our internal team to collaboratively drive the roadmap to success in 3 months. As a result, we landed two new multi-million dollar projects.”
- RA & Quality Management Director, Pharmaceutical CMO, Boston, Massachusetts
